BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 12894429)

  • 1. [Anneroth, Batsakis and Luna's modified classification as prognostic factor in patients with laryngeal carcinoma].
    Starska K; Kulig A; Łukomski M
    Otolaryngol Pol; 2003; 57(2):229-35. PubMed ID: 12894429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Histological clinical features of the primary tumor as prognostic factors in patients with laryngeal carcinoma].
    Starska K; Kulig A; Łukomski M
    Pol Merkur Lekarski; 2003 Jul; 15(85):55-60. PubMed ID: 14593961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading, and proliferation markers.
    Welkoborsky HJ; Hinni M; Dienes HP; Mann WJ
    Ann Otol Rhinol Laryngol; 1995 Jul; 104(7):503-10. PubMed ID: 7598360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The significance of the nucleolus organizer region antigen for the differentiation of laryngeal dysplasias and laryngeal carcinoma].
    Martin H; Greiner K; Beil M; Hufnagl P
    HNO; 1996 Jan; 44(1):22-6. PubMed ID: 8819725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of pre-epiglottic space invasion in supracricoid partial laryngectomy with cricohyoidopexy.
    Suoglu Y; Guven M; Kiyak E; Enoz M
    J Laryngol Otol; 2008 Jun; 122(6):623-7. PubMed ID: 17888196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic factors in larynx cancers].
    Vuralkan E; Akin I; Kuran G; Saka C; Akçayöz N; Alicura S
    Kulak Burun Bogaz Ihtis Derg; 2008; 18(4):221-6. PubMed ID: 19052489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between anti-apoptotic proteins survivin and Bcl-2, and response to treatment in patients undergoing post-operative RT for laryngeal cancer: a pilot study.
    Marioni G; Staffieri A; Lionello M; Tealdo G; Staffieri C; Giacomelli L; Friso ML; Stramare R; Ottaviano G; Blandamura S
    J Oral Pathol Med; 2013 Apr; 42(4):339-44. PubMed ID: 23126236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological validation of supracricoid partial laryngectomy in laryngeal cancer.
    Sun DI; Cho KJ; Cho JH; Joo YH; Jung CK; Kim MS
    Clin Otolaryngol; 2009 Apr; 34(2):132-9. PubMed ID: 19413611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic grading of malignancy and prognosis in glottic carcinoma of the larynx.
    Jakobsson PA
    Can J Otolaryngol; 1975; 4(5):885-92. PubMed ID: 1203794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relation between hypoxia-inducible factor (HIF)-1alpha expression with p53 expression and outcome in surgically treated supraglottic laryngeal cancer.
    Cabanillas R; Rodrigo JP; Secades P; Astudillo A; Nieto CS; Chiara MD
    J Surg Oncol; 2009 May; 99(6):373-8. PubMed ID: 19226532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Second carcinomas in cancers of the mouth cavity, pharynx and larynx. Clinical, histopathologic and cell kinetic findings].
    Esser D; Anke S; Roessner A; Freigang B
    Laryngorhinootologie; 2000 Aug; 79(8):478-82. PubMed ID: 11006912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KAI1 COOH-terminal interacting tetraspanin (KITENIN) expression in early and advanced laryngeal cancer.
    Lee JK; Yoon TM; Seo DJ; Sun EG; Bae JA; Lim SC; Choi YD; Lee JH; Joo YE; Kim KK
    Laryngoscope; 2010 May; 120(5):953-8. PubMed ID: 20422689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of cathepsin's-D tissular detection in laryngeal squamous cell carcinoma.
    Lentari I; Segas I; Kandiloros D
    Acta Otorhinolaryngol Belg; 2002; 56(4):383-9. PubMed ID: 12528259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of local failure in early laryngeal cancer.
    Lohynska R; Slavicek A; Bahanan A; Novakova P
    Neoplasma; 2005; 52(6):483-8. PubMed ID: 16284693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. nm23-H1 protein immunoreactivity in laryngeal carcinoma.
    Lee CS; Redshaw A; Boag G
    Cancer; 1996 Jun; 77(11):2246-50. PubMed ID: 8635091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoma in situ of the glottic larynx.
    Myssiorek D; Vambutas A; Abramson AL
    Laryngoscope; 1994 Apr; 104(4):463-7. PubMed ID: 8164486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ki-67, mini-chromosome maintenance 2 protein (MCM2) and geminin have no independent prognostic relevance for cancer-specific survival in surgically treated squamous cell carcinoma of the penis.
    May M; Burger M; Otto W; Hakenberg OW; Wieland WF; May D; Hofstädter F; Götz S; Niessl N; Fritsche HM; Birnkammer K; Gilfrich C; Peter J; Jain A; Koch S; Lebentrau S; Riedmiller H; Rössler W; Denzinger S; Brookman-May S; Gunia S
    BJU Int; 2013 Aug; 112(4):E383-90. PubMed ID: 23305250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High nuclear expression of the apoptosis inhibitor protein survivin is associated with disease recurrence and poor prognosis in laryngeal basaloid squamous cell carcinoma.
    Marioni G; Ottaviano G; Marchese-Ragona R; Giacomelli L; Bertolin A; Zanon D; Marino F; Staffieri A
    Acta Otolaryngol; 2006 Feb; 126(2):197-203. PubMed ID: 16428200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cyclooxygenase-2, vascular endothelial growth factor and matrix metalloproteinase-2 in patients with primary laryngeal carcinoma: a tissue microarray study.
    Dong P; Li X; Yu Z; Lu G
    J Laryngol Otol; 2007 Dec; 121(12):1177-83. PubMed ID: 17888194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of Ki-67 antigen expression in paraffin tissue blocks of laryngeal squamous cell carcinoma.
    Fumic-Dunkic L; Katic V; Janjanin S; Klapan I; Simuncic A; Vcev A
    Am J Otolaryngol; 2003; 24(2):106-10. PubMed ID: 12649825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.